CINV — Crucial Innovations Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Crucial Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st  | R2019 December 31st  | 2020 December 31st  | 2021 December 31st  | 2022 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | 0 | 0 | 0 | — | 
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.001 | 0 | 0 | 0.011 | 0 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.014 | 0.012 | 0 | — | — | 
| Total Assets | 0.015 | 0.012 | 0 | 0.011 | 0 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.029 | 0.048 | 0 | 0.034 | 0.066 | 
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.029 | 0.048 | 0 | 0.034 | 0.066 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.014 | -0.036 | -0 | -0.023 | -0.066 | 
| Total Liabilities & Shareholders' Equity | 0.015 | 0.012 | 0 | 0.011 | 0 | 
| Total Common Shares Outstanding |